Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 5/20 | 0.51 |
| ▸ | SLC6A3 | Q01959 | 5/20 | 0.50 |
| ▸ | SLC6A2 | P23975 | 4/20 | 0.50 |
| ▸ | SLC6A4 | P31645 | 3/20 | 0.50 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.50 |
| ▸ | HTR1A | P08908 | 1/20 | 0.50 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.50 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.50 |
| ▸ | DRD1 | P21728 | 1/20 | 0.50 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.50 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.50 |
| ▸ | DRD3 | P35462 | 1/20 | 0.50 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.50 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8938360 | 0.92 | SLC6A2 (0.51) | SIGMAR1SLC6A3SLC6A2SLC6A4CHRM2 | |
| SCHEMBL8938540 | 0.92 | HRH3 (0.49) | SIGMAR1SLC6A3SLC6A2SLC6A4CHRM2 | |
| SCHEMBL8938512 | 0.92 | SLC6A2 (0.51) | SIGMAR1SLC6A3SLC6A2SLC6A4CHRM2 | |
| SCHEMBL8938619 | 0.92 | SLC6A2 (0.48) | SIGMAR1SLC6A3SLC6A2SLC6A4CHRM2 | |
| SCHEMBL8938477 | 0.92 | SLC6A2 (0.51) | SIGMAR1SLC6A3SLC6A2SLC6A4CHRM2 | |
| SCHEMBL8938314 | 0.89 | SLC6A2 (0.48) | SIGMAR1SLC6A3SLC6A2SLC6A4CHRM2 | |
| SCHEMBL8938357 | 0.89 | SLC6A2 (0.48) | SLC6A3SLC6A2SLC6A4CHRM2HTR1A | |
| SCHEMBL8938421 | 0.89 | SLC6A2 (0.48) | SLC6A3SLC6A2SLC6A4CHRM2HTR1A | |
| SCHEMBL8938341 | 0.89 | HTR2A (0.45) | SIGMAR1SLC6A3SLC6A2SLC6A4CHRM2 | |
| SCHEMBL8938194 | 0.89 | SIGMAR1 (0.49) | SIGMAR1SLC6A3SLC6A2SLC6A4CHRM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5534626-A | SELECTIVE MUSCARINIC RECEPTOR ANTAGONIST INTERMEDIATES | PFIZER INC. (US) | 1996-07-09 | — | — | US | disclosed |
| US-5486527-A | Anticholinergic agents | PFIZER INC. (US) | 1996-01-23 | — | — | US | disclosed |
| US-5410046-A | Selective muscarinic receptor antagonists | PFIZER INC. (US) | 1995-04-25 | — | — | US | disclosed |
| EP-0511222-B1 | DISUBSTITUTED PIPERIDINES AND PYRROLIDINES AS ANTICHOLINERGIC AGENTS | PFIZER LTD (GB) | 1994-12-07 | — | — | EP | disclosed |
| US-5231104-A | Anticholinergic | PFIZER INC. (US) | 1993-07-27 | — | — | US | disclosed |
| EP-0350309-B1 | PIPERIDINE DERIVATIVES | Pfizer Limited (GB) | 1992-11-11 | — | — | EP | disclosed |
| EP-0511222-A1 | DISUBSTITUTED PIPERIDINES AND PYRROLIDINES AS ANTICHOLINERGIC AGENTS. | PFIZER LTD (GB) | 1992-11-04 | — | — | EP | disclosed |
| US-5089505-A | Anticholinergic agents | PFIZER INC. (US) | 1992-02-18 | — | — | US | disclosed |
| WO-1991010651-A1 | ANTICHOLINERGIC AGENTS | PFIZER LIMITED (GB) | 1991-07-25 | — | — | WO | disclosed |
| EP-0350309-A1 | Piperidine derivatives | Pfizer Limited (GB) | 1990-01-10 | — | — | EP | disclosed |